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Genotype and Phenotype Correlation in Patients with Comorbid Epilepsy and Intellectual Disability
Mohamed Taha, Jill Clayton-Smith
Mentor: Jill Clayton-Smith
Program: Neurology
Epilepsy and intellectual disability 
comorbidity is a common condition with 
great medical and psychological impact on a 
patient’s life and their family members.
We sought to investigate the genotype and 
phenotype of patients with epilepsy and 
intellectual disability comorbidity who had 
negative karyotyping and microarrays results, 
to find any statistical correlations of positive 
findings with specific clinical features, and 
to calculate the diagnostic rates of targeted 
exome sequencing panel and whole exome 
sequencing.
In 80 patients with the comorbid condition, 
recruited by the Manchester Centre of 
Genomic Medicine, we analyzed the relevant 
clinical information, collected data from 76 
patients who were tested by a targeted exome 
sequencing panel assembled to diagnose this 
condition, and gathered the data of 16 patients 
who subsequently went on to be tested by 
whole exome sequencing.
The overall detection rate of pathogenic 
and likely pathogenic variants in genes 
associated with epilepsy and intellectual 
disability comorbidity was 24%. There was 
a 17% detection rate by the targeted exome 
sequencing panel (13/76), and 33% by whole 
exome sequencing (5/15). There was no 
significant statistical correlation identified 
between genotype and phenotype variables. 
The STXBP1 gene was the gene most 
frequently identified to carry a disease causing 
variant, seen in 5 patients.
This study demonstrated the considerable 
utility of the use of targeted exome sequencing 
as well as whole exome sequencing in this 
condition for detection of causative genetic 
variants. The absence of statistical correlation 
between the chances of finding a pathogenic 
result and a specific phenotype, suggests that 
the clinical presentations within this group 
are not always distinctive or that the use of a 
much larger study group is needed to improve 
the statistical power. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.020
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Background: There are conflicting reports 
on the validity of the multi-biomarker disease 
activity (MBDA) score to assess rheumatoid 
arthritis (RA) disease activity. We performed a 
systematic review of the MBDA and meta-
analysis of the correlation between the MBDA 
and other RA disease activity measures. 
Methods: A systematic review was 
performed, searching MEDLINE, EMBASE, 
Scopus, Google Scholar, and the Cochrane 
Library from inception to March 7, 2017. 
Study details, MBDA performance, and 
study quality were assessed by independent 
reviewers. Correlations of the MBDA with 
composite RA disease activity measures were 
pooled using random-effects meta-analyses. 
Results: Twenty-two studies were identified 
in the systematic review, of which 8 (n=3,242 
assays) reported correlations of the MBDA 
with RA disease activity measures. Pooling 
results from these eight studies in the meta-
analysis, the MBDA demonstrated modest 
correlations with DAS28-CRP (r = 0.41, 95% 
CI 0.36-0.46) and DAS28-ESR (r = 0.48, 
95% CI 0.38-0.58) with weaker correlations 
observed with SDAI (r = 0.35, 95% CI 0.26-
0.43), CDAI (r = 0.26, 95% CI 0.19-0.33), 
and RAPID3 (r = 0.23, 95% CI 0.19-0.27). 
Correlations between change in MBDA and 
change in disease activity measures ranged 
from r = 0.53 (DAS28-ESR) to r = 0.26 
(CDAI).
Conclusion: The MBDA demonstrates 
moderate convergent validity with DAS28-
CRP and DAS28-ESR, but weaker 
correlations with SDAI, CDAI, and RAPID3. 
While it appears to complement existing RA 
disease activity measures, further assessment 
of the MBDA’s performance characteristics is 
warranted. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.021
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Hantavirus Cardiopulmonary Syndrome 
(HCPS) is a relatively uncommon zoonotic 
viral illness classically associated with the 
southwestern United States. It is important for 
clinicians to include HCPS on the differential 
for diffuse alveolar hemorrhage (DAH) and 
acute respiratory distress syndrome (ARDS), 
as HCPS carries a high mortality rate and 
commonly goes unrecognized. 
A middle-aged patient presented with fever 
and cough and was found to be hypotensive 
and thrombocytopenia. Despite being started 
on broad spectrum antibiotics, the patient’s 
respiratory status rapidly declined, requiring 
intubation and ICU level of care. Chest 
radiographs revealed diffuse pulmonary 
41 
infiltrates and computed tomography of the 
chest revealed severe bilateral pulmonary 
consolidation and edema resembling ARDS. 
A bronchoalveolar lavage revealed diffuse 
alveolar hemorrhage. All infectious and 
rheumatologic workup was negative except 
for a significantly elevated Hantavirus IgM 
which was reflexed to a state public health 
laboratory.  In the United States, HCPS is 
most commonly caused by the Sin Nombre 
virus (SNV), a member of the Hantavirus 
genus transmitted primarily by the deer 
mouse. This host has an extensive habitat 
across much of North America but the 
majority of confirmed HCPS cases occur in 
the Southwestern U.S. All clinically important 
Hantaviruses are transmitted by aerosolized 
droplets from urine, feces or saliva of rodents. 
The cardiopulmonary phase of HCPS is 
characterized by capillary leak into the 
alveoli, causing bilateral diffuse interstitial 
edema and pulmonary hemorrhage that 
may resemble ARDS on imaging. Patients 
with suspected HCPS should be screened 
for Hantavirus IgM and IgG. Positive IgM 
samples from U.S. residents are sent to a 
Public Health Laboratory for SNV-specific 
antibody testing. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.022
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